IRIS
LAULETTA, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.975
AS - Asia 2.237
EU - Europa 1.882
SA - Sud America 529
Continente sconosciuto - Info sul continente non disponibili 243
AF - Africa 83
OC - Oceania 3
Totale 10.952
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.856
SG - Singapore 977
IT - Italia 637
CN - Cina 554
BR - Brasile 417
SE - Svezia 311
HK - Hong Kong 236
RU - Federazione Russa 193
DE - Germania 164
FI - Finlandia 113
UA - Ucraina 113
VN - Vietnam 107
FR - Francia 106
GB - Regno Unito 103
IN - India 74
BD - Bangladesh 64
CA - Canada 63
AR - Argentina 42
TR - Turchia 35
MX - Messico 34
ID - Indonesia 31
IQ - Iraq 23
JP - Giappone 23
ES - Italia 22
PL - Polonia 22
BE - Belgio 21
NL - Olanda 20
CO - Colombia 19
ZA - Sudafrica 18
PK - Pakistan 17
VE - Venezuela 16
CI - Costa d'Avorio 15
IE - Irlanda 15
SA - Arabia Saudita 15
MA - Marocco 13
UZ - Uzbekistan 12
AT - Austria 11
PH - Filippine 11
MY - Malesia 10
JO - Giordania 8
LT - Lituania 8
CL - Cile 7
CZ - Repubblica Ceca 7
EC - Ecuador 7
NP - Nepal 7
PY - Paraguay 7
TN - Tunisia 7
BO - Bolivia 6
EG - Egitto 6
KE - Kenya 6
AZ - Azerbaigian 5
PA - Panama 5
BH - Bahrain 4
ET - Etiopia 4
LB - Libano 4
NI - Nicaragua 4
UY - Uruguay 4
AU - Australia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
JM - Giamaica 3
KR - Corea 3
MU - Mauritius 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
LY - Libia 2
OM - Oman 2
PE - Perù 2
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GF - Guiana Francese 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HT - Haiti 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MG - Madagascar 1
MK - Macedonia 1
MM - Myanmar 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 10.706
Salva come PNG Salva come JPEG
Città #
Fairfield 623
Ashburn 596
Singapore 536
San Jose 442
Chandler 414
Woodbridge 392
Milan 256
Seattle 255
Cambridge 252
Jacksonville 248
Houston 240
Nyköping 238
Hong Kong 235
Beijing 199
Wilmington 189
Ann Arbor 172
Council Bluffs 111
New York 100
Rome 95
Lauterbourg 80
Roxbury 76
Los Angeles 75
Lawrence 73
Santa Clara 71
Nanjing 70
Dallas 68
Boardman 55
Bari 53
Des Moines 53
Brooklyn 46
Helsinki 46
Princeton 46
Munich 38
Inglewood 37
São Paulo 35
Columbus 32
San Diego 29
Buffalo 27
Ho Chi Minh City 25
Nanchang 24
Hebei 23
London 23
Tokyo 23
Figino 22
Brussels 21
Toronto 21
Dong Ket 20
Hanoi 20
Shenyang 20
Montreal 19
Jakarta 18
Phoenix 17
San Francisco 17
Chicago 16
Denver 16
Falkenstein 16
Warsaw 16
Abidjan 15
Jiaxing 15
Dublin 14
Orem 14
Pune 14
Tianjin 14
Frankfurt am Main 13
Ankara 12
Belo Horizonte 12
Boston 12
Moscow 12
Tashkent 12
Turin 12
Changsha 11
Atlanta 10
Guangzhou 10
Jinan 10
Stockholm 10
The Dalles 10
Chennai 9
Grafing 9
Nuremberg 9
Paris 9
Amman 8
Baghdad 8
Brasília 8
Charlotte 8
Guarulhos 8
Ostuni 8
Poplar 8
Shanghai 8
Casablanca 7
Haiphong 7
Johannesburg 7
Kuala Lumpur 7
Rio de Janeiro 7
Amsterdam 6
Brescia 6
Brno 6
Catania 6
Curitiba 6
Dearborn 6
Elk Grove Village 6
Totale 7.389
Salva come PNG Salva come JPEG
Nome #
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 233
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 223
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases 208
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 206
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma 206
CD5/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia 204
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 200
HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2 184
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 174
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience 167
B CELLS AND HCV: AN INFECTION MODEL OF AUTOIMMUNITY 162
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage 162
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 160
IN SITU SIMULTANEOUS DETECTION OF HEPATITIS C VIRUS RNA AND HEPATITIS C VIRUS-RELATED ANTIGENS IN HEPATOCELLULAR CARCINOMA 156
B-cell depletion in the treatment of mixed cryoglobulinemia. 154
Hepatitis C virus infection and mixed cryoglobulinemia 152
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience 150
HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from hcv-infected patients with peripheral neuropathy 150
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 148
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy 147
Caratterizzazione di lesione metastatica da carcinoma della mammella con angioecografia. Caso clinico 145
Imaging evaluation of pulmonary and non-ischaemic cardiovascular manifestations of covid-19 145
Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study 141
Barrett's esophagus and esophageal cancer: An overview. 139
A Challenging Case of Visceral Leishmaniasis 138
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins 137
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay 136
Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial. 136
H. pylori infection and gastric cancer: state of the art (review). 136
Hepatitis C virus infection and mixed cryoglobulinemia: a striking association 134
C4d: a valuable marker of activation of the classical complement pathway in mixed cryoglobulinemia 132
INCREASED SERUM LEVELS OF THE CHEMOKINE CXCL13 AND UP-REGULATION OF ITS GENE EXPRESSION ARE DISTINCTIVE FEATURES OF HCV-RELATED CRYOGLOBULINEMIA AND CORRELATE WITH ACTIVE CUTANEOUS VASCULITIS 131
Role of B-cell attracting chemokine-1 in HCV-related cryoglobulinemic vasculitis 130
MONOCLONAL ANTIBODY TREATMENT OF MIXED CRYOGLOBULINEMIA RESISTANT TO INTERFERON ALPHA WITH AN ANTI-CD20 128
Features of peripheral CD8+CD57+ lymphocytes in patients with autoimmune hemolytic anemia 128
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study. 126
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection 123
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study 123
null 122
Antikörper gegen hepatitis-C-viren in humanen intravenösen immunoglobulinen. 121
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 118
HEPATITIS C VIRUS RNA AND CORE PROTEIN IN KIDNEY GLOMERULAR AND TUBULAR STRUCTURES ISOLATED WITH LASER CAPTURE MICRODISSECTION 117
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia 116
Assessment of total Hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia. 116
Crioglobulinemia mista e infezione da HCV 115
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite (HCV) con e senza crioglobulinemia mista 114
MIXED CRYOGLOBULINEMIA: A MODEL OF VIRUS-RELATED DISEASE IN INTERNAL MEDICINE 112
Basi molecolari dell’associazione tra virus epatite e carcinoma epatocellulare 111
HCV-ASSOCIATED B CELL CLONALITIES IN THE LIVER DO NOT CARRY THE T(14; 18) CHROMOSOMAL TRANSLOCATION 111
REPLY TO THE LETTER TO THE EDITOR "ANDROGEN DEPRIVATION THERAPY AND RISK OF RHEUMATOID ARTHRITIS IN PATIENTS WITH LOCALIZED PROSTATE CANCER" by YANG et al. 111
Cryoglobulinemic Vasculitis 109
Alcolizzazione percutanea del piccolo HCC. Casistica personale 104
IMMUNOCHEMICAL AND BIOMOLECULAR STUDIES OF CIRCULATING IMMUNE COMPLEXES ISOLATED FROM PATIENTS WITH ACUTE AND CHRONIC HEPATITIS C VIRUS INFECTION 103
Association Between Mixed Cryoglobulinemia, Translocation (14;18), and Persistence of Occult HCV Lymphoid Infection After Treatment 103
Espansione clonale dei linfociti B intraepatici ottenuti da portatori cronici del virus C dell'epatite con e senza crioglobulinemia mista 102
PEGYLATED INTERFERON-A, RIBAVIRIN AND RITUXIMAB COMBINED THERAPY OF HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA: A LONG-TERM STUDY 100
Vasculiti primarie sistemiche 98
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 97
HCV, Mixed Cryoglobulinemia and Malignant Lymphoproliferation 96
Cellule ematopoietiche staminali CD34+ e infezione cronica da virus C dell'epatite 96
null 96
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study 93
In reply. Transarterial chemoembolization plus sorafenib... 93
T cell receptor variable beta gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia 91
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis 90
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study 90
Potential neutralizing properties of anti-E2 antibodies in HCV-infected patients with lymphoproliferative disorders. 89
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 87
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 87
VIROLOGICAL ANALYSIS AND PHENOTIPIC CHARACTERIZATION OF PERIPHERAL BLOOD LYMPHOCYTES OF HEPATITIS C VIRUS-INFECTED PATIENTS WITH AND WITHOUT MIXED CRYOGLOBULINEMIA 86
Autoimmune Hepatitis: Factors Involved in Initiation and Methods of Diagnosis and Treatment 86
Double filtration plasmapheresis in the treatment of leg ulcers in the course of type IHCV-positive cryoglobulinemia 84
Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature 81
P87 MEDIASTINAL SYNDROME REVEALED HEART LOCALIZATION OF A PRIMARY MEDIASTINAL B-CELL LYMPHOMA 79
Le tecniche di biologia molecolare nello studio dei tessuti fissati e paraffinati 78
null 78
Trattamento con interferone pegilato-α2b in monoterapia o in associazione con ribavirina e amantadina in pazienti affetti da epatite cronica attiva HCV-correlata non responsivi a interferone non-pegilato 76
ROLE OF THE RECEPTOR FOR THE GLOBULAR DOMAIN OF C1Q PROTEIN IN THE PATHOGENESIS OF CRYOGLOBULIN-RELATED VASCULAR DAMAGE 75
La vasculite crioglobulinemica: aspetti clinico-patogenetici 73
Natural interferon-Α versus its combination with 6-methyl prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term randomized, controlled study 71
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 68
Hepatitis C virus-related autoimmunity before and after viral clearance: a single center, prospective, observational study 67
Trattamento antivirale in pazienti affetti da epatite cronica attiva HCV correlata e transaminasi normali 67
Serum IgM in type II mixed cryoglobulinemia recognize HCV E2 peptides 66
Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinemia 66
Cryoglobulinemia: the "cold" problem in cardiac surgery, a single-center experience and a literature review 63
Immunodetection of hepatitis C virus (HCV)-related antigens in tissues: problems and perspectives 61
null 61
Pulmonary Embolism in COVID-19 Patients Is Not Related to a Deterioration of Tissue Oxygenation 58
Termoablazione a radiofrequenza vs alcolizzazione percutanea nel trattamento del piccolo epatocarcinoma. Studio prospettico, randomizzato 55
The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements 54
Role of the receptor for the globular domain of C1q protein in the pathogenesis of HCV-related cryoglobulin vascular damage 52
Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis. 51
null 47
Double-filtration plasmapheresis in the treatment of leg ulcers in cryoglobulinemia 45
Terapia della sindrome crioglobulinemica 38
⁠From liver to cardiovascular system: the MASLD–ASCVD continuum 4
Totale 10.952
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.130
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022524 0 0 9 23 26 55 28 29 41 52 114 147
2022/20231.097 146 117 78 98 105 168 14 153 169 4 25 20
2023/2024380 33 77 16 25 34 93 20 19 4 8 4 47
2024/20251.595 35 25 131 44 31 147 200 140 58 79 235 470
2025/20263.555 475 158 156 331 401 196 436 80 435 277 146 464
2026/2027444 105 217 122 0 0 0 0 0 0 0 0 0
Totale 10.952